Founded in 2004, Diurnal is a UK-based, globally-focused specialty pharma company developing high quality products for the life-long treatment of chronic endocrine conditions.
They are committed to addressing major unmet clinical and patient needs in hormone replacement, initially by developing and marketing products for the rare orphan diseases Congenital Adrenal Hyperplasia (CAH) and Adrenal Insufficiency (AI).
Diurnal’s expertise and innovative research activities focus on circadian-based endocrinology (mimicking the body’s natural hormone levels), which has yielded novel product candidates being trialled in patients prior to the submission of a marketing authorisation application.
REACH INVESTORS, RAISE CAPITAL
NEX Exchange is used by entrepreneurs and individuals to manage their financial challenges. We give companies of all sizes, from micro to mid-caps, access to a public quote or a fully regulated listing. For investors, we offer simple access to a diverse range of dynamic, small and medium sized companies and to a variety of equity or debt products. For ambitious companies and investors, NEX Exchange is a platform for growth.
At NEX Exchange our goal is straightforward: we want to put investors in touch with investment opportunities and help businesses attract new capital. Investors can trade through UK stockbrokers. Advisory, discretionary, execution only and online services are available. NEX Exchange securities are eligible for inclusion in SIPPs and ISAs and exempt from stamp duty while NEX Exchange Growth Market securities may be eligible for IHT, CGT & EIS reliefs amongst others.
Prairie Mining (PDZ)
Venture Life (VLG)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group’s product range and pipeline currently include food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin. The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group’s international distribution partners.